<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0180">
 <label>36</label>
 <element-citation publication-type="journal" id="sbref0180">
  <person-group person-group-type="author">
   <name>
    <surname>Gniadecki</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Assaf</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Bagot</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Dummer</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Duvic</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Knobler</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Ranki</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Schwandt</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Whittaker</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>The optimal use of bexarotene in cutaneous T-cell lymphoma</article-title>
  <source>Br. J. Dermatol.</source>
  <volume>157</volume>
  <year>2007</year>
  <fpage>433</fpage>
  <lpage>440</lpage>
  <pub-id pub-id-type="pmid">17553039</pub-id>
 </element-citation>
</ref>
